Joel J. Heidelbaugh - Concepedia

Author

Joel J. Heidelbaugh

Also Known As

J HEIDELBAUGH, J. Heidelbaugh, J. J. Heidelbaugh, Joel Heidelbaugh, Joel J Heidelbaugh, Joel J. Heidelbaugh, Santiago Horgan, Seifert, Bohumil

187

Publications

Citations

H-Index

Concepts

All Affiliations

University of Michigan Ypsilanti District Library University of Minnesota University of California, Los Angeles Minneapolis VA Health Care System

About

Joel J. Heidelbaugh is an author at University of Michigan specializing in medicine, gastroenterology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	2.1K
2	Public Health	4	4	155
3	Health Sciences	1	1	186
4	Social Sciences	1	1	94
5	Clinical Nutrition	1	1	186

Joel J. Heidelbaugh

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Peyronie’s Disease: AUA Guideline Ajay Nehra, Ralph Alterowitz, Daniel J. Culkin, The Journal of Urology	2015	393
Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. Joel J. Heidelbaugh, Michael Bruderly PubMed Liver Function TestsGastroenterologyPathologyFatty Liver DiseaseUnited States	2006	341
Overutilization of proton-pump inhibitors: what the clinician needs to know Joel J. Heidelbaugh, Andrea H. Kim, Robert S. Chang, Therapeutic Advances in Gastroenterology MedicineGastrointestinal PharmacologyPatient SafetyGastroenterologyClinical Pharmacology	2012	312
American Gastroenterological Association Institute Guideline on the Use of Thiopurines, Methotrexate, and Anti–TNF-α Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease Jonathan P. Terdiman, Claudia Gruss, Joel J. Heidelbaugh, Gastroenterology InflammationChronic Inflammatory DiseasesAnti–tnf-α Biologic DrugsAnti-inflammatoryGastrointestinal Pharmacology	2013	230
Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications Joel J. Heidelbaugh Therapeutic Advances in Drug Safety NutritionHypertensionClinical ImplicationsGastroenterologyPharmacotherapy	2013	186
Magnitude and Economic Impact of Inappropriate Use of Stress Ulcer Prophylaxis in Non-ICU Hospitalized Patients Joel J. Heidelbaugh, John M. Inadomi The American Journal of Gastroenterology	2006	175
Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting. Joel J. Heidelbaugh, Kathleen L Goldberg, John M. Inadomi PubMed	2010	154
The Spectrum of Constipation-Predominant Irritable Bowel Syndrome and Chronic Idiopathic Constipation: US Survey Assessing Symptoms, Care Seeking, and Disease Burden Joel J. Heidelbaugh, Margie Stelwagon, Steven A. Miller, The American Journal of Gastroenterology	2015	152
AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea Anthony Lembo, Shahnaz Sultan, Lin Chang, Gastroenterology Functional Gastrointestinal DisorderPharmacological ManagementGastrointestinal PharmacologyPharmacologyGastroenterology	2022	141
Management of the ingrown toenail. Joel J. Heidelbaugh, Hobart Lee PubMed Improper TrimmingOperative TreatmentComplete Nail ExcisionSurgeryOperative Management	2009	134

Page 1